When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. Keeping that in mind, here are three stocks facing legitimate challenges and some alternatives worth exploring instead.

Choice Hotels (CHH)

Consensus Price Target: $111.93 (-0.2% implied return)

With almost 100% of its properties under franchise agreements, Choice Hotels (NYSE: CHH) is a hotel franchisor known for its diverse brand portfolio including Comfort Inn, Quality Inn, and Clarion.

Why Should You Dump CHH?

1. Softer revenue per room over the past two years suggests it might have to invest in new amenities such as restaurants and bars to attract customers
2. Poor free cash flow margin of 9.4% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
3. Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

Choice Hotels is trading at $112.13 per share, or 16.1x forward P/E. Read our free research report to see why you should think twice about including CHH in your portfolio.

Illumina (ILMN)

Consensus Price Target: $136.11 (11.7% implied return)

Pioneering the ability to read the human genome at unprecedented speed and affordability, Illumina (NASDAQ: ILMN) develops and sells advanced DNA sequencing and microarray technologies that allow researchers and clinicians to analyze genetic variations and functions.

Why Does ILMN Give Us Pause?

1. Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
2. Annual earnings per share growth of 1.5% underperformed its revenue over the last five years, partly because it diluted shareholders
3. Low returns on capital reflect management’s struggle to allocate funds effectively

Illumina’s stock price of $121.88 implies a valuation ratio of 24.1x forward P/E. Check out our free in-depth research report to learn more about why ILMN doesn’t pass our bar.

German American Bancorp (GABC)

Consensus Price Target: $48.60 (10.4% implied return)

Founded in 1910 during a wave of community banking expansion in the Midwest, German American Bancorp (NASDAQ: GABC) is a financial holding company that provides banking, wealth management, and insurance services across southern Indiana and Kentucky.

Why Are We Hesitant About GABC?

1. Efficiency ratio is projected to stay flat over the coming year, suggesting its fixed cost leverage is currently maxed out
2. Performance over the past two years shows its incremental sales were less profitable, as its 2% annual earnings per share growth trailed its revenue gains
3. Annual tangible book value per share growth of 1.5% over the last five years was below our standards for the banking sector

At $44.02 per share, German American Bancorp trades at 1.3x forward P/B. To fully understand why you should be careful with GABC, check out our full research report (it’s free).

Stocks We Like More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.